Neumora Therapeutics Announces Initiation of Phase 1B Study of Nmra-511 for Treatment of Alzheimer’s Disease Agitation
Neumora Therapeutics宣佈啓動NMRA-511治療阿爾茨海默病焦慮症的1B期研究。
Neumora Therapeutics Announces Initiation of Phase 1B Study of Nmra-511 for Treatment of Alzheimer’s Disease Agitation
Neumora Therapeutics宣佈啓動NMRA-511治療阿爾茨海默病焦慮症的1B期研究。
譯文內容由第三人軟體翻譯。